Diseases /

Malignant Urethral Neoplasm

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: Abnormal malignant growth of cells in the urethra (lower urinary tract). [1]

Malignant urethral neoplasms most frequently harbor alterations in TP53, FGFR3, PIK3CA, CDKN2A, and KDM6A [2].

Most Commonly Altered Genes in Malignant Urethral Neoplasm

TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, FGFR3 Mutation, and TP53 Exon 8 Mutation are the most common alterations in malignant urethral neoplasm [2].

Top Alterations in Malignant Urethral Neoplasm

Clinical Trials

View Clinical Trials for Malignant Urethral Neoplasm

Significant Genes in Malignant Urethral Neoplasm

ERBB2 +

Disease Details

Synonyms
Malignant Neoplasm of the Urethra, Malignant Tumor of Urethra, Malignant Neoplasm of Urethra, Urethral Cancer, Malignant Tumor of the Urethra, Malignant Urethra Tumor, Malignant Urethral Tumor, Urethra Cancer, Malignant Urethra Neoplasm
Parent(s)
Urethral Neoplasm
Children
Posterior Urethral Malignant Neoplasm, Mucosal Melanoma of the Urethra, Female Urethral Malignant Neoplasm, Urethral Carcinoma, Anterior Urethral Malignant Neoplasm, Paraurethral Gland Cancer, and Male Urethral Malignant Neoplasm

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.